Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A Proof-of-Concept Study.

Alzheimer’s disease EEG source connectivity LORETA feature selection. lewy body dementia machine learning

Journal

Current Alzheimer research
ISSN: 1875-5828
Titre abrégé: Curr Alzheimer Res
Pays: United Arab Emirates
ID NLM: 101208441

Informations de publication

Date de publication:
2021
Historique:
received: 24 12 2020
revised: 06 06 2021
accepted: 19 07 2021
pubmed: 30 10 2021
medline: 2 4 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

Early differentiation between Alzheimer's disease (AD) and Dementia with Lewy Bodies (DLB) is important for accurate prognosis, as DLB patients typically show faster disease progression. Cortical neural networks, necessary for human cognitive function, may be disrupted differently in DLB and AD patients, allowing diagnostic differentiation between AD and DLB. This proof-of-concept study assessed whether the application of machine learning techniques to data derived from resting-state electroencephalographic (rsEEG) rhythms (discriminant sensor power, 19 electrodes) and source connectivity (between five cortical regions of interest) allowed differentiation between DLB and AD. Clinical, demographic, and rsEEG datasets from DLB patients (N=30), AD patients (N=30), and control seniors (NOld, N=30), matched for age, sex, and education, were taken from our international database. Individual (delta, theta, alpha) and fixed (beta) rsEEG frequency bands were included. The rsEEG features for the classification task were computed at both sensor and source levels. The source level was based on eLORETA freeware toolboxes for estimating cortical source activity and linear lagged connectivity. Fluctuations of rsEEG recordings (band-pass waveform envelopes of each EEG rhythm) were also computed at both sensor and source levels. After blind feature reduction, rsEEG features served as input to support vector machine (SVM) classifiers. Discrimination of individuals from the three groups was measured with standard performance metrics (accuracy, sensitivity, and specificity). The trained SVM two-class classifiers showed classification accuracies of 97.6% for NOld vs. AD, 99.7% for NOld vs. DLB, and 97.8% for AD vs. DLB. Three-class classifiers (AD vs. DLB vs. NOld) showed classification accuracy of 94.79%. These promising preliminary results should encourage future prospective and longitudinal cross-validation studies using higher resolution EEG techniques and harmonized clinical procedures to enable the clinical application of these machine learning techniques.

Sections du résumé

BACKGROUND
Early differentiation between Alzheimer's disease (AD) and Dementia with Lewy Bodies (DLB) is important for accurate prognosis, as DLB patients typically show faster disease progression. Cortical neural networks, necessary for human cognitive function, may be disrupted differently in DLB and AD patients, allowing diagnostic differentiation between AD and DLB.
OBJECTIVE
This proof-of-concept study assessed whether the application of machine learning techniques to data derived from resting-state electroencephalographic (rsEEG) rhythms (discriminant sensor power, 19 electrodes) and source connectivity (between five cortical regions of interest) allowed differentiation between DLB and AD.
METHODS
Clinical, demographic, and rsEEG datasets from DLB patients (N=30), AD patients (N=30), and control seniors (NOld, N=30), matched for age, sex, and education, were taken from our international database. Individual (delta, theta, alpha) and fixed (beta) rsEEG frequency bands were included. The rsEEG features for the classification task were computed at both sensor and source levels. The source level was based on eLORETA freeware toolboxes for estimating cortical source activity and linear lagged connectivity. Fluctuations of rsEEG recordings (band-pass waveform envelopes of each EEG rhythm) were also computed at both sensor and source levels. After blind feature reduction, rsEEG features served as input to support vector machine (SVM) classifiers. Discrimination of individuals from the three groups was measured with standard performance metrics (accuracy, sensitivity, and specificity).
RESULTS
The trained SVM two-class classifiers showed classification accuracies of 97.6% for NOld vs. AD, 99.7% for NOld vs. DLB, and 97.8% for AD vs. DLB. Three-class classifiers (AD vs. DLB vs. NOld) showed classification accuracy of 94.79%.
CONCLUSION
These promising preliminary results should encourage future prospective and longitudinal cross-validation studies using higher resolution EEG techniques and harmonized clinical procedures to enable the clinical application of these machine learning techniques.

Identifiants

pubmed: 34711165
pii: CAR-EPUB-118594
doi: 10.2174/1567205018666211027143944
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

956-969

Subventions

Organisme : São Paulo Research Foundation (FAPESP)
ID : 2018/036551
Organisme : Brazilian National Council for Scientific Development (CNPq)
ID : 306350/2019-0

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Rodrigo San-Martin (R)

Center for Mathematics, Computation and Cognition, Federal University of the ABC, São Bernardo do Campo, Brazil.

Francisco J Fraga (FJ)

Engineering, Modeling and Applied Social Sciences Center, Federal University of the ABC, Santo André, Brazil | Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Roberta Lizio (R)

IRCCS SDN, Napoli,Italy.

Giuseppe Noce (G)

IRCCS SDN, Napoli, Italy.

Flavio Nobili (F)

Clinica neurologica, IRCCS Ospedale Policlinico San Martino, Genova,Italy | Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Dario Arnaldi (D)

Clinica neurologica, IRCCS Ospedale Policlinico San Martino, Genova,Italy | Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Fabrizia D'Antonio (F)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Carlo De Lena (C)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Bahar Güntekin (B)

Department of Biophysics, School of Medicine; REMER Research Center, Istanbul Medipol University, Istanbul, Turkey.

Lutfu Hanoğlu (L)

Department of Neurology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

John Paul Taylor (JP)

Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.

Ian McKeith (I)

Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.

Fabrizio Stocchi (F)

Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.

Raffaele Ferri (R)

Oasi Research Institute - IRCCS, Troina, Italy.

Marco Onofrj (M)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti,Italy.

Susanna Lopez (S)

Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Laura Bonanni (L)

Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Claudio Babiloni (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome,Italy | San Raffaele of Cassino, Cassino (FR), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH